our data suggest that the experimentally observed synergistic cell kill between methotrexate and 5-fu has clinical relevance and that the sequential mfl regimen is a superior alternative to 5-fu alone in the treatment of patients with advanced symptomatic colorectal cancer .
C0066495
mfl regimen
C0016360
fu